Frontiers in Immunology (Feb 2022)

Localized Intra-Cavitary Therapy to Drive Systemic Anti-Tumor Immunity

  • Vera S. Donnenberg,
  • Vera S. Donnenberg,
  • Vera S. Donnenberg,
  • Patrick L. Wagner,
  • Patrick L. Wagner,
  • James D. Luketich,
  • James D. Luketich,
  • David L. Bartlett,
  • David L. Bartlett,
  • Albert D. Donnenberg,
  • Albert D. Donnenberg,
  • Albert D. Donnenberg

DOI
https://doi.org/10.3389/fimmu.2022.846235
Journal volume & issue
Vol. 13

Abstract

Read online

Metastasis to the pleural and peritoneal cavities is a common terminal pathway for a wide variety of cancers. This article explores how these unique environments both promote aggressive tumor behavior and suppresses anti-tumor immunity, and ways in which local delivery of protein therapeutics can leverage the contained nature of these spaces to a therapeutic advantage, achieving high intra-cavital concentrations while minimizing systemic toxicity.

Keywords